EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

A new T‐antigen negative HEK293 cell line with improved AAV productivity

Coralie Croissant, Joshua Armitano, Bertrand Lazuech, Danijel Švec, Cyril Pugin, Anaïs Guesdon, Louise Bryan, Antonio Castro, Léa Neuhaus, Giulia Fonti, Jacopo Martinis, Maria J Wurm und 2 weitere

Biotechnology and Bioengineering · 2023

DOI: 10.1002/bit.28414 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biotechnology and Bioengineering, 2023. Verfasst von Coralie Croissant und 13 weiteren Autor:innen. Beteiligte Einrichtung: ExcellGene SA, Monthey, Switzerland. Hauptthemen laut MEDLINE: Antigens, Viral, Tumor, Genetic Vectors. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Viral vectors for gene therapy, such as recombinant adeno‐associated viruses, are produced in human embryonic kidney (HEK) 293 cells. However, the presence of the SV40 T‐antigen‐encoding CDS SV40GP6 and SV40GP7 in the HEK293T genome raises safety issues when these cells are used in manufacturing for clinical purposes. We developed a new T‐antigen‐negative HEK cell line from ExcellGene's proprietary HEKExpress,® using the CRISPR‐Cas9 strategy. We obtained a high number of clonally‐derived cell populations and all of them were demonstrated T‐antigen negative. Stability study and AAV production evaluation showed that the deletion of the T‐antigen‐encoding locus did not impact neither cell growth nor viability nor productivity. The resulting CMC‐compliant cell line, named HEKzeroT,® is able to produce high AAV titers, from small to large scale.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antigens, Viral, TumorGenetic VectorsHumansHEK293 CellsDependovirus

Stichwörter der Autor:innen

AAVHEK293T-antigengene therapymanufacturing

Substanzen

Antigens, Viral, Tumor

Autor:innen und Institutionen

  • ExcellGene SA, Monthey, Switzerland.

ORCID-Profile: Paco Pino

Zitieren

APA

Croissant, C., Armitano, J., Lazuech, B., Švec, D., Pugin, C., Guesdon, A., Bryan, L., Castro, A., Neuhaus, L., Fonti, G., Martinis, J., Wurm, M. J., Wurm, F. M., & Pino, P. (2023). A new T‐antigen negative HEK293 cell line with improved AAV productivity. Biotechnology and Bioengineering. https://doi.org/10.1002/bit.28414

Vancouver

Croissant C, Armitano J, Lazuech B, Švec D, Pugin C, Guesdon A, et al. A new T‐antigen negative HEK293 cell line with improved AAV productivity. Biotechnology and Bioengineering. 2023. doi:10.1002/bit.28414

BibTeX
@article{Croissant2023,
  author = {Croissant, Coralie and Armitano, Joshua and Lazuech, Bertrand and Švec, Danijel and Pugin, Cyril and Guesdon, Anaïs and Bryan, Louise and Castro, Antonio and Neuhaus, Léa and Fonti, Giulia and Martinis, Jacopo and Wurm, Maria J and Wurm, Florian M and Pino, Paco},
  title = {A new T‐antigen negative HEK293 cell line with improved AAV productivity},
  journal = {Biotechnology and Bioengineering},
  year = {2023},
  doi = {10.1002/bit.28414}
}
Kostenlos starten →